1![Purines / Medicine / Clinical medicine / Azathioprine / Mercaptopurine / Inflammatory bowel disease / Thiopurine / Immunosuppressive drug / Allopurinol / Tioguanine / Management of ulcerative colitis Purines / Medicine / Clinical medicine / Azathioprine / Mercaptopurine / Inflammatory bowel disease / Thiopurine / Immunosuppressive drug / Allopurinol / Tioguanine / Management of ulcerative colitis](/pdf-icon.png) | Add to Reading ListSource URL: www.bsg.org.ukLanguage: English - Date: 2013-09-11 11:10:29
|
---|
2![March 31, 2015 Ajinomoto Pharmaceuticals Co., Ltd. Kissei Pharmaceutical Co., Ltd. Ajinomoto Pharmaceuticals and Kissei announce partnership for joint development and marketing March 31, 2015 Ajinomoto Pharmaceuticals Co., Ltd. Kissei Pharmaceutical Co., Ltd. Ajinomoto Pharmaceuticals and Kissei announce partnership for joint development and marketing](https://www.pdfsearch.io/img/e0737aad501ca923ef2f8bc63a13d03a.jpg) | Add to Reading ListSource URL: www.ajinomoto-seiyaku.co.jpLanguage: English - Date: 2015-03-30 23:15:54
|
---|
3![NOTE: NURSE MUST INITIAL EACH INDIVIDUAL ORDER NOTE: NURSE MUST INITIAL EACH INDIVIDUAL ORDER](https://www.pdfsearch.io/img/b029d3687f99cae3d9d55a87bd5f8ebb.jpg) | Add to Reading ListSource URL: ugotabug.med.miami.eduLanguage: English - Date: 2013-09-16 11:21:56
|
---|
4![HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use OPDIVO safely and effectively. See full prescribing information for OPDIVO. OPDIVO (nivolumab) injection, for intrav HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use OPDIVO safely and effectively. See full prescribing information for OPDIVO. OPDIVO (nivolumab) injection, for intrav](https://www.pdfsearch.io/img/9126952d18171bfd5554fb2ced33f344.jpg) | Add to Reading ListSource URL: packageinserts.bms.comLanguage: English - Date: 2015-03-04 21:16:39
|
---|
5![Aliment Pharmacol Ther 2005; 21: 1111–doi: j02458.x Comparison of two different daily dosages (2.4 vs. 1.2 g) of oral mesalazine in maintenance of remission in ulcerative colitis patients Aliment Pharmacol Ther 2005; 21: 1111–doi: j02458.x Comparison of two different daily dosages (2.4 vs. 1.2 g) of oral mesalazine in maintenance of remission in ulcerative colitis patients](https://www.pdfsearch.io/img/58d9393445567a012637bc6799bcd5f8.jpg) | Add to Reading ListSource URL: www.drfalkpharma.ruLanguage: English - Date: 2005-05-10 02:05:12
|
---|
6![CONSUMER MEDICINE INFORMATION NAVELBINE® ORAL 20, 30, 40, 80 mg Soft Capsules vinorelbine tartrate What is in this leaflet CONSUMER MEDICINE INFORMATION NAVELBINE® ORAL 20, 30, 40, 80 mg Soft Capsules vinorelbine tartrate What is in this leaflet](https://www.pdfsearch.io/img/055a18ec34f206708082e9a935069d44.jpg) | Add to Reading ListSource URL: www.pierre-fabre.com.auLanguage: English - Date: 2015-02-10 00:22:24
|
---|
7![Monoclonal antibodies / Immunosuppressants / Clinical research / Pharmacology / Infliximab / Adalimumab / Management of ulcerative colitis / Ulcerative colitis / Disease-modifying antirheumatic drug / Medicine / Health / Autoimmune diseases Monoclonal antibodies / Immunosuppressants / Clinical research / Pharmacology / Infliximab / Adalimumab / Management of ulcerative colitis / Ulcerative colitis / Disease-modifying antirheumatic drug / Medicine / Health / Autoimmune diseases](/pdf-icon.png) | Add to Reading ListSource URL: www.pbs.gov.auLanguage: English - Date: 2014-11-12 19:13:31
|
---|
8![PREGNANCY AND THE OSTOMATE The management of a pregnant patient with a stoma is uncommon. There is no large published series and most reviews consist of information obtained from questionnaires sent to patients who have PREGNANCY AND THE OSTOMATE The management of a pregnant patient with a stoma is uncommon. There is no large published series and most reviews consist of information obtained from questionnaires sent to patients who have](https://www.pdfsearch.io/img/271aed90d98bf7fd30bdd46568be454c.jpg) | Add to Reading ListSource URL: www.australianstoma.com.auLanguage: English - Date: 2011-11-04 07:27:11
|
---|
9![WATAG Advisory Note RE: FORMULARY LISTING OF INFLIXIMAB (REMICADE®) FOR SEVERE ULCERATIVE COLITIS The formulary listing of infliximab for the treatment of ulcerative colitis is hereby approved according to the following WATAG Advisory Note RE: FORMULARY LISTING OF INFLIXIMAB (REMICADE®) FOR SEVERE ULCERATIVE COLITIS The formulary listing of infliximab for the treatment of ulcerative colitis is hereby approved according to the following](https://www.pdfsearch.io/img/303971495be3ea3d9320a6b37976d62d.jpg) | Add to Reading ListSource URL: www.watag.org.auLanguage: English - Date: 2012-12-16 22:40:24
|
---|
10![PO Box 2345, Beijing[removed], China www.wjgnet.com [removed] World J Gastroenterol 2006 October 7; 12(37): [removed]World Journal of Gastroenterology ISSN[removed] PO Box 2345, Beijing[removed], China www.wjgnet.com [removed] World J Gastroenterol 2006 October 7; 12(37): [removed]World Journal of Gastroenterology ISSN[removed]](https://www.pdfsearch.io/img/337feac0e47e5fb11555bb0be52417ae.jpg) | Add to Reading ListSource URL: www.wjgnet.comLanguage: English - Date: 2012-10-11 02:40:42
|
---|